Qualitative and quantitative composition - Medsafe
1 DATA SHEET FLIXOTIDE ® Inhaler Fluticasone propionate Inhaler (CFC-Free) (50, 125 or 250 micrograms per actuation). Qualitative and quantitative composition
Download Qualitative and quantitative composition - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
for Respiratory Therapists, - irccouncil.org
www.irccouncil.org2013 A Guide to Aerosol Delivery Devices for Respiratory Therapists, 3rd Edition American Association for Respiratory Care † † † ...
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzVANNAIR Data Sheet 120418 Copyright 4 Patients should be reminded to take their VANNAIR maintenance dose as prescribed, even when asymptomatic. They should also be ...
Glyceryl Trinitrate Spray PL 16431 0023-UKPAR - GOV.UK
www.mhra.gov.ukMHRA- UKPAR - Glyceryl Trinitrate Spray 400µg per metered dose sublingual spray - PL 16431/0023 - 6 - 2.7 Manufacturing process The proposed manufacturing process is consistent with the details registered for the cross-
Public Assessment Report Decentralised Procedure Combisal ...
www.mhra.gov.ukPAR Combisal 25/50, 25/125 and 25/250 microgram per metered dose pressurised inhaler, suspension UK/H/6076//001-003/DC 5 For the full list of all side effects reported with Combisal, see …
Validation of a Questionnaire for Assessing Adherence to ...
www.neumologia-pediatrica.comherence can cause therapeutic failure, need to increase medication dosage or add other medications, need for costly diagnostic testing, and unnecessary morbidity and even mortality.1,2 Self-report of asthma medication use by the patient (or by parents or caregivers in the case of children)
Principles of Metered-Dose Inhaler Design
www.rcjournal.comIntroduction: Development of the Pressurized Metered-Dose Inhaler In the first half of the 20th century, inhaled drugs for the treatment of asthma and chronic obstructive pulmonary
Hydrofluoroalkane as a propellant for pressurized metered ...
www.scielo.brHydrofluoroalkane as a propellant for inhalers ΠIbiapina CC et alii Jornal de Pediatria - Vol. 80, No.6, 2004 443 evaluated 18 adult patients for six weeks, compared the efficiency of fluticasone-HFA versus fluticasone-CFC.
Able Spacer TM Comparison Data - WyMedical
www.wymedical.com.auAble Spacer TM Comparison Data Able Spacer™ is a valved holding chamber. It is designed to assist with metered dose inhaler (MDI) aerosol medication delivery. The silicone rubber